Pursuant to section 20 of the Medicines Act 1981, the Minister of Health gave his consent to the distribution in New Zealand of the new medicines listed in the Schedule to a notice published in the New Zealand Gazette, 14 January 2010, No. 1, page 63.
This corrigendum amends the notice by revoking the entry for the following new medicine:
Schedule
Product: Pravastatin
Active Ingredient: Pravastatin sodium 80mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Explanatory Note: This note is not part of the corrigendum but is intended to explain this corrigendum. The revocation of the entry for this medicine is required to correct an administrative error.
Dated this 12th day of March 2010.
MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).